Julie E. Bauman

Lovelace Medical Center - DowntownAlbuquerque, New Mexico - 87102 (505-727-8000) Hematology Oncology Associates, PCAlbuquerque, New Mexico - 87106 (505-272-4551) University of New Mexico Cancer ...Albuquerque, New Mexico - 87106 University of New Mexico Health ...Albuquerque, New Mexico - 87131 (505-272-2590) |
- CLINICAL TRIALS 6
- CONDITIONS10
- INTERVENTIONS13
- SINCE2006

Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
November 2009 - June 2015

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Temsirolimus (Torisel ) and Erlotinib (Tarceva ) in Platinum-Refractory/Ineligible Advanced Squamous Cell Carcinoma
December 2009 - November 2013

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
November 2007 - January 2014

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer
August 2009 - August 2012

Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
June 2006 - July 2011
Lung Neoplasms
Carcinoma
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Oropharyngeal Neoplasms
Radiation Injuries
Hypopharyngeal Neoplasms
Laryngeal Neoplasms
Nasopharyngeal Neoplasms
Intensity-Modulated Radiation Therapy
Quality-Of-Life Assessment
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Erlotinib Hydrochloride
3-Dimensional Conformal Radiation Therapy
Cetuximab
Tarceva, Torisel
Gleevec, Paclitaxel



